AN OBSERVATIONAL STUDY ON CARDIOVASCULAR INVOLVEMENT IN COVID RECOVERED PATIENTS

NCT05710796 | Completed

• 1 other identifier: IECHS/CCP/DOPP/09/04
• Study Type: observational
• Target: 500
• Locations: 1 country
• Sites: 1

Brief Summary

Aim of the study is to evaluate the prevalence and bring awareness ofcardiovascular complications in COVID-19 recovered patients. Study is conducted at single site, which is Srinivasa Heart Centre, Warangal, Telangana state in India for the duration of 4 months. The sample size is calculated 500 patients and the study is cohort, observational study. Patient consent has been taken before enrolment.

Conditions

Gender Discrimination; Cardiac Event; Complication

Keywords

Cardiovascular involvement; COVID 19 disease; Gender difference

Outcome Measures

Primary Outcomes (1)

• ECG, Lipid profile, TMT, and 2D Echo

  The following tests are performed to every individuals and relevant report are considered

  September 2021 to February 2022

Study Arms (3)

All population

The total population reported to Cardiology department during enrollment period

Behavioral: Difference in gender, response to disease, diagnostic test values

COVID recovered

Patient having history of COVID 19 disease

Behavioral: Difference in gender, response to disease, diagnostic test values

No history of COVID

Population those who never exposed to COVID 19 disease and never suffers

Behavioral: Difference in gender, response to disease, diagnostic test values

Interventions

Difference in gender, response to disease, diagnostic test values BEHAVIORAL

Gender difference: Prevalence of disease in male vs female Response to disease: Which group is more prone to cardiac involvement Diagnostic tests: Diagnostic confirmation of disease

All population; COVID recovered; No history of COVID

Eligibility Criteria

• Age: 18 Years - 100 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patient reporting to the cardiology department during study period

You may qualify if:

• Patients who are willing to participate
• Patients having previous COVID-19 treatment record
• Prescriptions reported during the study period
• The prescription which is legible and complete

You may not qualify if:

• Patients who are not willing to participate
• The patient having no history of COVID-19 and available data

Sponsors & Collaborators

• Kakatiya University: lead

Study Sites (1)

Srinivasa Heart Centre

Warangal, Telangana, 506001, India

Location

MeSH Terms

Conditions

Sexism; Cardiovascular Diseases

Interventions

Sex

Condition Hierarchy (Ancestors)

Prejudice; Social Behavior; Behavior; Social Discrimination

Intervention Hierarchy (Ancestors)

Reproductive Physiological Phenomena; Reproductive and Urinary Physiological Phenomena

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Department of Pharmacy Practice

Study Record Dates

• First Submitted: January 30, 2023
• First Posted: February 2, 2023
• Study Start: September 1, 2021
• Primary Completion: February 1, 2022
• Study Completion: April 29, 2022
• Last Updated: February 3, 2023

Record last verified: 2023-02

Locations

IN (1)